Results 261 to 270 of about 370,662 (286)
Some of the next articles are maybe not open access.

Evolution of multidisciplinary care: Experience of the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP).

Journal of Clinical Oncology, 2012
67 Background: A key aim of the NCCCP is to develop and improve the quality of multidisciplinary care (MDC). An assessment tool with nine key elements relevant to MDC structure and operations was developed to assess MDC maturity and set goals for continued quality improvement at individual sites and across the network.
Eliot Lawrence Friedman   +7 more
openaire   +1 more source

Criteria for charity care at National Cancer Institute (NCI) -designated cancer centers.

JCO Oncology Practice
262 Background: According to the American Cancer Society, nearly half (47%) of cancer patients and survivors incurred medical debts to pay for cancer care, although most (98%) had health care coverage (2024 Survivor Views Survey). The financial toxicity from high cost of cancer care is itself a
Lucas T. Go   +2 more
openaire   +1 more source

Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI)

Investigational New Drugs, 1996
Well-designed and carefully conducted pediatric phase 1 trials are critical to the process of evaluating new agents for potential benefit in children with cancer, and the National Cancer Institute (NCI) has for a number of years sponsored pediatric phase I trials.
M, Smith, P T, Ho
openaire   +2 more sources

Leading the way: The National Cancer Institute’s (NCI) single IRB for multi-site research.

Journal of Clinical Oncology, 2017
e18259 Background: NCI instituted a Central IRB (CIRB) with voluntary participation in 2001 for its late-phase trials and demonstrated that efficiency could be improved and costs reduced (Wagner et al JCO, 2010; 28). As a forerunner to the new NIH policy for single IRBs for all NIH multi-site trials (Hudson et al. JAMA Oct 4, 2010), NCI implemented a
Holly A. Massett   +12 more
openaire   +1 more source

Impact of National Cancer Institute (NCI)-mandated scientific review on protocol development and content.

Journal of Clinical Oncology, 2014
6586 Background: The National Cancer Institute (NCI) requirement that all clinical trials involving cancer patients at NCI-designated cancer centers undergo a scientific review in addition to Insti...
Ning Ning   +3 more
openaire   +1 more source

Evaluating productivity in clinical research programs: The National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP)

Journal of Medical Systems, 1992
This paper outlines an approach to studying productivity in clinical research programs that incorporates environmental, organizational, provider, and patient specific factors in the model of production process. We describe how this approach has been applied to the National Cancer Institute's (NCI) Community Clinical Oncology Programs (CCOPs).
D M, Hynes   +4 more
openaire   +2 more sources

Catastrophic Health Expenditure Among Cancer Patients In National Cancer Institute (NCI), Malaysia And Its Influencing Factors

Malaysian Journal of Medicine and Health Sciences
Introduction: This study looks at the patient’s perspective to determine the Catastrophic Health Expenditure (CHE) level and the possible factors which can be associated with CHE in cancer patients. Methods: This cross sectional study was done in National Cancer Institute, Malaysia with 206 patients sampled using the multilevel sampling method and data
Sharifa Ezat Wan Puteh   +2 more
openaire   +1 more source

MC13-0092 The National Cancer Institute (NCI) specimen resource locator

European Journal of Cancer, 2013
J. Demchok   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy